Comparison

BrainCheck, Inc. vs CANTAB

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

BrainCheck, Inc.

Assess cognitive function and aid in the early diagnosis of Alzheimer's and dementia. This FDA-registered medical device provides results within 15 minutes, helping to identify potential brain health conditions early.

Highlights
  • Cognitive function assessment
  • Aid in dementia diagnosis
  • FDA-registered Class II medical device
  • Results in 15 minutes
  • Supports iPad use
Features
Read full description

66% of dementia goes undiagnosed. Early diagnosis is critical to prevent or slow dementia. BrainCheck is an FDA-registered Class II medical device used to assess cognitive function and aid in the diagnosis of Alzheimer's and Dementia within 15 minutes. Note: We recommend taking and administering tests on an iPad. Disclaimer: BrainCheck is not a diagnostic tool and does not treat brain health conditions.

About

CANTAB

This application is exclusively for registered study participants. It allows users to check in regularly to engage with research studies and monitor their personal progress.

Highlights
  • Study participation
  • Regular check-ins
  • Progress monitoring
  • Study updates
Read full description

This app is only for use by registered study participants. Install it and check in regularly to participate in the study and keep up to date with your progress.

Screenshots

BrainCheck, Inc.2 screens
CANTAB3 screens

Verdict

The call

The clearest difference is rating: BrainCheck, Inc. at 2.8 against CANTAB's 2.5. BrainCheck, Inc. also leads on ratings volume (35 vs 2) and device support (3 vs 1). On price, update cadence, ads and in-app purchases there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

BrainCheck, Inc. holds the better App Store score, 2.8 against 2.5. That said, the two scores are not equally well evidenced: BrainCheck, Inc. has 35 ratings behind it against 2, so its average is the more settled of the two.

UpkeepUpdate frequency

BrainCheck, Inc. ships an update every 2 months, CANTAB every 3 months. Both last shipped on October 3, 2026.

Scorecard4 real differences · 6 level
BrainCheck, Inc. versus CANTAB: the parameters behind the verdict, then further details
ParameterBrainCheck, Inc.CANTAB
PriceFreeFree
Rating2.8 (35 ratings) — better2.5 (2 ratings)
Positive reviews35.3% of reviews—
Number of ratings35 — better2
Update frequencyEvery 2 months — betterEvery 3 months
AdsNoNo
In-app purchasesNoNo
MonetizationFreeFree
DevicesiPhone, iPad, iPod — betteriPhone
Requires iOS11.0 — better17.0
Further details — not scored
Size61 MB72 MB
Age rating12+17+
DeveloperBrainCheck, Inc.Cambridge Cognition Limited

Customer experience

BrainCheck, Inc.

All ratings35 ratings
Positive42.9%
Neutral2.9%
Negative54.3%
Written reviews17 reviews
Positive35.3%
Neutral5.9%
Negative58.8%

CANTAB

All ratings2 ratings
Positive50.0%
Neutral0.0%
Negative50.0%

In-app purchases

None

BrainCheck, Inc.

No in-app purchases

None

CANTAB

No in-app purchases

Questions

Is BrainCheck, Inc. free?
BrainCheck, Inc. is free to download, with no in-app purchases.
Is CANTAB free?
CANTAB is free to download, with no in-app purchases.
Which has better reviews, BrainCheck, Inc. or CANTAB?
BrainCheck, Inc. is rated higher. BrainCheck, Inc. averages 2.8 out of 5 from 35 ratings, while CANTAB averages 2.5 from 2 ratings.
Do BrainCheck, Inc. or CANTAB have ads?
Neither BrainCheck, Inc. nor CANTAB shows ads.
Which is updated more often, BrainCheck, Inc. or CANTAB?
BrainCheck, Inc. ships an update every 2 months, and CANTAB every 3 months. Most recently, BrainCheck, Inc. was updated on October 3, 2026 and CANTAB on October 3, 2026.

Other comparisons